Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
Transl Cancer Res ; 13(4): 1665-1684, 2024 Apr 30.
Article in English | MEDLINE | ID: mdl-38737689

ABSTRACT

Background: Early-onset colorectal cancer (EOCRC) is increasing in incidence and poses a growing threat. Urgent research is needed, especially in survival analysis, to enhance comprehension and treatment strategies. This study aimed to explore the risk factors associated with cancer-specific mortality (CSM) and other-cause mortality (OCM) in patients with EOCRC. Additionally, the study aimed to develop a nomogram predicting CSM using a competitive risk model and validate its accuracy through the use of training, using internal and external cohorts. Methods: Data from EOCRC patients were collected from the Surveillance, Epidemiology, and End Results (SEER) database (2008-2017). EOCRC patients who were treated at a tertiary hospital in northeast China between 2014 and 2020 were also included in the study. The SEER data were divided into the training and validation sets at a 7:3 ratio. A univariate Cox regression model was employed to identify prognostic factors. Subsequently, multivariate Cox regression models were applied to ascertain the presence of independent risk factors. A nomogram was generated to visualize the results, which were evaluated using the concordance index (C-index), area under the curve (AUC), and calibration curves. The clinical utility was assessed via decision curve analysis (DCA). Results: Multivariable Cox regression analysis demonstrated that factors such as race, tumor differentiation, levels of carcinoembryonic antigen (CEA), marital status, histological type, American Joint Committee on Cancer (AJCC) stage, and surgical status were independent risk factors for CSM in EOCRC patients. In addition, age, gender, chemotherapy details, CEA levels, marital status, and AJCC stage were established as independent risk factors for OCM in individuals diagnosed with EOCRC. A nomogram was developed using the identified independent risk factors, demonstrating excellent performance with a C-index of 0.806, 0.801, and 0.810 for the training, internal validation, and external validation cohorts, respectively. The calibration curves and AUC further confirmed the accuracy and discriminative ability of the nomogram. Furthermore, the DCA results indicated that the model had good clinical value. Conclusions: In this study, a competing risk model for CSM was developed in EOCRC patients. The model demonstrates a high level of predictive accuracy, providing valuable insights into the treatment decision-making process.

2.
Eur J Gastroenterol Hepatol ; 36(6): 750-757, 2024 Jun 01.
Article in English | MEDLINE | ID: mdl-38555605

ABSTRACT

OBJECTIVE: The objective of this study was to evaluate the safety and effectiveness of radiofrequency ablation (RFA) and transcatheter arterial chemoembolization (TACE) in the treatment of large hepatic hemangiomas (LHH) (5-9.9 cm in diameter). METHODS AND MATERIALS: This study retrospectively collected data from 82 patients with LHH treated at Chaoyang Central Hospital. The study analyzed the differences in postoperative efficacy, operative time, blood routine, liver and kidney function on the first day after surgery, postoperative hospitalization time and postoperative complications. RESULTS: There were statistically significant differences in indicators such as white blood cell count, alanine aminotransferase, aspartate aminotransferase and total bilirubin on the first day after surgery between the RFA group (39 cases) and the TACE group (43 cases) ( P < 0.001). Compared to RFA, LHH patients treated with TACE had a general complication rate of 39.5% (vs. 43.6%; P = 0.7), a procedure-related complication rate of 30.2% (vs. 59.0%; P = 0.009), an effective rate at 6-12 months postoperatively of 55.8% (vs. 82.1%; P = 0.01), an operating-time of 41.2 ± 14.9 min (vs. 100.8 ± 35.5 min; P < 0.001) and hospitalization costs of 17052.7 ± 1364.8 yuan (vs. 30952.1 ± 4327.6 yuan; P < 0.001). CONCLUSION: This study indicates that the efficacy of RFA in treating LHH is significantly superior to TACE. Microwave ablation and RFA appear to be safe treatments for LHH. The TACE group exhibited shorter operating-time, lower hospitalization costs and lower demands on cardiopulmonary function.


Subject(s)
Chemoembolization, Therapeutic , Hemangioma , Liver Neoplasms , Operative Time , Humans , Male , Female , Liver Neoplasms/therapy , Middle Aged , Retrospective Studies , Treatment Outcome , Hemangioma/therapy , Adult , Chemoembolization, Therapeutic/methods , Chemoembolization, Therapeutic/adverse effects , Radiofrequency Ablation/adverse effects , Radiofrequency Ablation/methods , Length of Stay , Aged , Postoperative Complications/etiology , Catheter Ablation/methods , Catheter Ablation/adverse effects , Time Factors , Tumor Burden
3.
J Int Med Res ; 51(7): 3000605231183781, 2023 Jul.
Article in English | MEDLINE | ID: mdl-37466195

ABSTRACT

Single-port laparoscopic appendectomy (SPLA) has become a good alternative to the traditional surgical treatment of acute appendicitis, due to its advantages of small incision, mild postoperative pain, short hospital stay, and good cosmetic effect. However, the further application of SPLA has been restricted by its relatively long operating time, high level of operating difficulty, and increased equipment and technical requirements. Clinical teams worldwide have attempted to improve and optimize SPLA technical protocols and equipment to maintain stable intraoperative pneumoperitoneal pressure, improve the 'triangle relationship' of operating angles, and develop new surgical procedures with less trauma and higher cost-effectiveness. Here, new SPLA techniques reported over the past decade are reviewed and compared, with the aim of providing new insights into technical improvements, equipment upgrades and clinical studies in the coming years.


Subject(s)
Appendicitis , Laparoscopy , Humans , Appendectomy , Appendicitis/surgery , Laparoscopy/methods , Pain, Postoperative/surgery , Acute Disease , Treatment Outcome
4.
Biomark Med ; 17(22): 921-933, 2023 11.
Article in English | MEDLINE | ID: mdl-38235563

ABSTRACT

Aim: To explore the relationship between inflammatory markers and prolonged postoperative ileus (PPOI), and to establish a nomogram for predicting PPOI. Patients & methods: The data of 229 patients were analyzed retrospectively. Univariate and multivariate logistic regression analysis were used to analyze the risk factors affecting the occurrence of PPOI. The predictive model of PPOI was established and verified internally. Results: Postoperative PPOI occurred in 87 (38.0%) of all 229 patients. Our study showed that age, preoperative neutrophil-lymphocyte ratio and changes in neutrophil-lymphocyte ratio were independent risk factors for PPOI. Conclusion: The nomograms established based on these independent risk factors have good predictive efficacy and may be able to guide clinicians to individualize the diagnosis and treatment.


Subject(s)
Colorectal Neoplasms , Ileus , Humans , Nomograms , Retrospective Studies , Postoperative Complications/diagnosis , Postoperative Complications/etiology , Risk Factors , Ileus/diagnosis , Ileus/etiology , Ileus/epidemiology , Colorectal Neoplasms/complications , Colorectal Neoplasms/surgery
5.
Arch Dermatol Res ; 311(10): 761-772, 2019 Dec.
Article in English | MEDLINE | ID: mdl-31396694

ABSTRACT

Artesunate (ART) is the derivative of artemisinin isolated from the traditional Chinese medicine qinghao. Although several studies reported the efficiency of artesunate in the treatment of malaria, inhibiting fibroblasts and collagen synthesis, the association between artesunate and scar formation is unclear. The research was designed to study the significance of artesunate (ART) on the expression of transforming growth factor (TGF-ß1) and small mother against decapentaplegic (SMAD3) in rabbit's ear hypertrophic scar model. Twenty-four New Zealand white rabbits were randomly divided into six groups: control group, matrix group, low-concentration artesunate group (0.48%), medium-concentration artesunate group (0.96%), high-concentration artesunate group (1.92%) and silicone gel group. Punched defects were established on each rabbit's ear which resulted in a hypertrophic scar. On the 28th day, topical artesunate creams were applied twice a day except on the control group. On the 56th day, scar samples were collected for histopathology and immunoassay. Hematoxylin and eosin staining, Van Gieson staining, immunohistochemistry and Western blot analysis were done. Amongst the six groups, findings showed that the medium-concentration artesunate group (0.92%) efficiently decreased hypertrophic scar formation and significantly reduced fibroblasts and collagen synthesis. The results had also shown a decrease in the expression of transforming growth factor (TGF-ß1) and declined small signal mother against decapentaplegic (Smad3). The overall study shows efficacy and mechanism of artesunate. It concluded that the medium concentration of artesunate (0.92%) could be an effective therapeutic agent for hypertrophic scars.


Subject(s)
Artesunate/administration & dosage , Cicatrix, Hypertrophic/drug therapy , Gene Expression Regulation/drug effects , Smad3 Protein/metabolism , Transforming Growth Factor beta1/metabolism , Administration, Cutaneous , Animals , Cicatrix, Hypertrophic/etiology , Cicatrix, Hypertrophic/pathology , Disease Models, Animal , Dose-Response Relationship, Drug , Ear , Female , Fibroblasts/drug effects , Fibroblasts/metabolism , Humans , Rabbits , Skin/cytology , Skin/drug effects , Skin/pathology , Skin Cream/administration & dosage , Wound Healing/drug effects
6.
Mycopathologia ; 170(1): 47-50, 2010 Jul.
Article in English | MEDLINE | ID: mdl-20224862

ABSTRACT

This is the first indigenous case of disseminated histoplasmosis reported from the Penicillium marneffei endemic area in southern China. It was diagnosed by histopathology of tissue, gross and microscopic morphology of the culture and PCR assay of the isolated fungus. Successful antifungal treatment was with itraconazole 400 mg/day for 5 months. This case suggests that histoplasmosis should be an important differential diagnosis in immunocompromised patients in southern China and South East Asia (the only endemic area for P. marneffei).


Subject(s)
Histoplasma/isolation & purification , Histoplasmosis/diagnosis , Adult , China , DNA, Fungal/chemistry , DNA, Fungal/genetics , DNA, Ribosomal Spacer/chemistry , DNA, Ribosomal Spacer/genetics , Female , Histoplasma/cytology , Histoplasma/genetics , Histoplasmosis/drug therapy , Histoplasmosis/pathology , Humans , Itraconazole/administration & dosage , Microscopy , Phylogeny , Sequence Analysis, DNA , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...